Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines (Q42646327)

4 November 2017

Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines (English)

1 reference

4 November 2017

0 references

visceral leishmaniasis

1 reference

Babaloo Z

1

1 reference

4 November 2017

Kaye PM

series ordinal

2

1 reference

4 November 2017

Eslami MB

series ordinal

3

1 reference

4 November 2017

1 January 2001

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

4 November 2017

1 reference

4 November 2017

95

1 reference

4 November 2017

1

1 reference

4 November 2017

85-88

1 reference

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Presence of Circulating Levels of Interferon- g , Interleukin-10 and Tumor Necrosis Factor- a in Patients with Visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Splenic cytokine responses in Indian kala-azar before and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Impaired development of Th2 cells in IL-13-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

T-cell and cytokine responses in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2801%2990344-X

7 January 2021

10.1016/S0035-9203(01)90344-X

Identifiers

DOI

1 reference

release_2bzwa6p275hgjndr7zdgfcmfjm

4 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2bzwa6p275hgjndr7zdgfcmfjm

24 November 2022

mapped directly with Wikidata item

1 reference